Physician profile
Ryan D Mcbride
NPI 1700060944
$3,766.64
in general payments reported to CMS, 2019-2025
18 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $214 · 2021: $113 · 2022: $91.74 · 2023: $1,723 · 2024: $602 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,562 · Travel and Lodging: $1,069 · Education: $4.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,562.39 |
| Travel and Lodging | $1,068.73 |
| Education | $4.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,305.05 | 2019-2025 | Salvation, Prostep, Prophecy |
| Organogenesis INC. | $436.53 | 2019-2024 | Affinity, Puraply |
| Depuy Synthes Sales INC. | $238.13 | 2019-2024 | Motoband, Minibunion |
| Convatec INC. | $225.92 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $218.31 | 2019-2021 | |
| Kerecis Limited | $75.53 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Djo, LLC | $43.95 | 2023-2024 | Cmf |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.90 | 2023 | Jublia |
| Medtronic, INC. | $31.88 | 2024 | Turbohawk |
| Paragon 28, INC. | $29.43 | 2019-2020 | |
| Prism Medical | $20.93 | 2025 | |
| In2bones USA, LLC | $19.12 | 2021 | |
| Orthofix Medical, INC. | $16.96 | 2024-2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $16.20 | 2025 | |
| Nabriva Therapeutics, Plc | $14.34 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.96 | 2022 | |
| Merck Sharp & Dohme LLC | $12.25 | 2019 | |
| Heron Therapeutics, INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.